Indiana Center for Recovery: Comprehensive Company Profile

Background

Overview

Founded in 2016, the Indiana Center for Recovery (ICFR) is a leading behavioral health treatment facility dedicated to providing comprehensive mental health and addiction services across the Midwest. With a mission to deliver evidence-based, innovative treatment, ICFR aims to transform the lives of individuals struggling with substance use disorders and co-occurring mental health conditions. The center operates ten locations throughout Indiana, offering a full continuum of care from crisis stabilization to outpatient support.

Mission and Vision

ICFR's mission is to deliver evidence-based, innovative treatment that changes the life of every patient that walks through its doors. The vision is to empower and inspire patients and families to pursue healthy lives, emphasizing a patient-centered approach that integrates medical expertise with compassionate care.

Industry Significance

As a prominent provider in the behavioral health sector, ICFR plays a crucial role in addressing the growing need for comprehensive mental health and addiction services in the Midwest. Its commitment to integrating traditional care with innovative therapies positions it as a significant contributor to the region's healthcare landscape.

Key Strategic Focus

Core Objectives

Comprehensive Care: Offer a full spectrum of services, including medical detoxification, residential inpatient treatment, partial hospitalization programs (PHP), intensive outpatient programs (IOP), and outpatient services.

Innovative Therapies: Integrate advanced treatment modalities such as Transcranial Magnetic Stimulation (TMS), Spravato® (esketamine) therapy, and GeneSight® genetic testing to enhance treatment outcomes.

Patient-Centered Approach: Provide personalized care tailored to individual needs, ensuring effective treatment for both substance use and mental health disorders.

Areas of Specialization

Dual Diagnosis Treatment: Address co-occurring mental health and substance use disorders simultaneously, utilizing evidence-based therapies like Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and Eye Movement Desensitization and Reprocessing (EMDR).

Advanced Therapies: Implement cutting-edge treatments such as TMS, Spravato® therapy, and GeneSight® testing to inform medication decisions and improve patient outcomes.

Key Technologies Utilized

Transcranial Magnetic Stimulation (TMS): Non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain, aiding in the treatment of depression and other mental health conditions.

Spravato® (Esketamine) Therapy: Rapid-acting nasal spray approved for treatment-resistant depression, offering a new avenue for patients unresponsive to traditional therapies.

GeneSight® Testing: Genetic testing that helps clinicians tailor medication plans based on individual genetic profiles, reducing trial-and-error prescribing.

Primary Markets and Conditions Targeted

Substance Use Disorders: Treatment for alcohol, opioids, stimulants, and other substances.

Mental Health Conditions: Addressing anxiety, depression, trauma-related disorders, and mood disorders.

Dual Diagnosis: Integrated treatment for individuals with both mental health and substance use disorders.

Financials and Funding

Funding History

Specific details regarding total funds raised and recent funding rounds are not publicly disclosed. The company operates as a privately held entity, focusing on reinvestment into its facilities and services to enhance patient care.

Financial Performance

Estimated Annual Revenue: Approximately $72.2 million.

Employee Growth: The company experienced a 28% increase in total headcount last year, indicating expansion and increased service capacity.

Pipeline Development

Key Pipeline Candidates

ICFR continually evaluates and integrates new treatment modalities to enhance patient outcomes. While specific pipeline candidates are not publicly detailed, the center's commitment to innovation suggests ongoing development in advanced therapeutic options.

Stages of Clinical Trials or Product Development

As a treatment provider, ICFR does not engage in clinical trials or product development but focuses on implementing evidence-based therapies and treatments.

Target Conditions

Substance Use Disorders: Including alcohol, opioids, and stimulants.

Mental Health Disorders: Such as depression, anxiety, and trauma-related conditions.

Anticipated Milestones

ICFR aims to expand its service offerings and integrate additional advanced therapies to improve treatment outcomes continually.

Technological Platform and Innovation

Proprietary Technologies

ICFR utilizes proprietary treatment protocols and integrates advanced technologies to enhance patient care, including:

Advanced Therapeutic Modalities: Incorporation of TMS, Spravato® therapy, and GeneSight® testing into treatment plans.

Personalized Treatment Plans: Use of genetic testing and advanced diagnostics to tailor therapies to individual patient needs.

Significant Scientific Methods

Cognitive Behavioral Therapy (CBT): A structured, time-limited psychotherapy that aims to identify and change negative thought patterns and behaviors.

Dialectical Behavior Therapy (DBT): A form of CBT that focuses on teaching coping skills to manage emotional distress.

Eye Movement Desensitization and Reprocessing (EMDR): A psychotherapy treatment designed to alleviate the distress associated with traumatic memories.

AI-Driven Capabilities

While specific AI-driven capabilities are not detailed, ICFR's integration of GeneSight® testing indicates a commitment to utilizing advanced technologies to inform treatment decisions.

Leadership Team

Key Executives

Dr. Michael Kane, MD, ABPN: Chief Medical Officer. Dr. Kane oversees medical strategy and clinical operations across ten treatment facilities, leading the organization’s expansion and ensuring high-quality care.

Jackie Daniels, LCSW, CADAC: Director of Clinical Development. Ms. Daniels leads the clinical team, focusing on program development and implementation of evidence-based therapies.

David Debruicker, LCSW, LCAC: Director of Outpatient Programs. Mr. Debruicker manages outpatient services, ensuring continuity of care and support for patients in recovery.

Leadership Changes

No recent significant changes or appointments within the company's leadership have been publicly disclosed.

Competitor Profile

Market Insights and Dynamics

The behavioral health treatment market in the Midwest is experiencing growth due to increasing awareness of mental health issues and the rising prevalence of substance use disorders. ICFR's comprehensive service offerings position it well to meet the diverse needs of this expanding market.

Competitor Analysis

Key competitors in the region include:

Heritage Center: Specializes in addiction treatment with an estimated revenue of $16 million and 66 employees.

Brentwood Meadows: Focuses on mental health services, reporting $32.1 million in revenue and 119 employees.

American Pain Center: Offers pain management and addiction services, with $26.7 million in revenue and 77 employees.

These competitors vary in size and service offerings but collectively contribute to a competitive landscape in the behavioral health sector.

Strategic Collaborations and Partnerships

ICFR maintains partnerships with insurance providers to ensure treatment affordability and accessibility. Specific details regarding other strategic collaborations are not publicly disclosed.

Operational Insights

ICFR's comprehensive service model, integration of advanced therapies, and patient-centered approach provide a competitive advantage in delivering effective and personalized care.

Strategic Opportunities and Future Directions

Strategic Roadmap

Expansion of Services: Continue to broaden the range of treatment modalities and services offered to meet evolving patient needs.

Technological Integration: Further incorporate advanced technologies and therapies to enhance treatment efficacy and patient outcomes.

Community Engagement: Strengthen community outreach and education to raise awareness and reduce stigma associated with mental health and addiction.

Future Business Directions

ICFR aims to solidify its position as a leading provider of comprehensive behavioral health services in the Midwest by focusing on innovation, quality care, and patient satisfaction.

Opportunities for Expansion

Potential opportunities include expanding service offerings, increasing the number of treatment facilities, and exploring new therapeutic modalities to address a broader spectrum of mental health and addiction issues.

Positioning for Future Objectives

ICFR's commitment to evidence-based practices, innovative therapies, and patient-centered care positions it well to achieve its future objectives and continue making a significant impact in the behavioral health sector.

indiana-center-for-recovery